Regenerative medicine strategies for treatment of neurogenic bladder

Roberto Soler, Claudius Fullhase, Anthony Atala

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Neurogenic bladder is a general term encompassing various neurologic dysfunctions in the bladder and external urethral sphincter caused by damage or disease. Therapeutic management options fall into the categories of conservative, minimally invasive or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics to bladder tissue, numerous complications can ensue. Regenerative medicine uses combinations of cells and/or biomaterials to encourage regeneration of healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using the principles of regenerative medicine have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the US FDA, are ongoing in the USA in both children and adults to further evaluate the safety and efficacy of this technology for regenerating bladders. More studies are in progress and additional advances in this field can be anticipated.

Original languageEnglish
Pages (from-to)177-184
Number of pages8
JournalTherapy
Volume6
Issue number2
DOIs
StatePublished - Mar 1 2009
Externally publishedYes

Fingerprint

Neurogenic Urinary Bladder
Regenerative Medicine
Urinary Bladder
Therapeutics
Meningomyelocele
Biocompatible Materials
Urethra
Neurologic Manifestations
Regeneration
Clinical Trials
Technology
Safety

Keywords

  • Bladder replacement
  • Neurogenic bladder
  • Regenerative medicine
  • Stem cell
  • Tissue engineering

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)

Cite this

Regenerative medicine strategies for treatment of neurogenic bladder. / Soler, Roberto; Fullhase, Claudius; Atala, Anthony.

In: Therapy, Vol. 6, No. 2, 01.03.2009, p. 177-184.

Research output: Contribution to journalArticle

Soler, Roberto ; Fullhase, Claudius ; Atala, Anthony. / Regenerative medicine strategies for treatment of neurogenic bladder. In: Therapy. 2009 ; Vol. 6, No. 2. pp. 177-184.
@article{be82b4298e29434c819c9a74eda6812d,
title = "Regenerative medicine strategies for treatment of neurogenic bladder",
abstract = "Neurogenic bladder is a general term encompassing various neurologic dysfunctions in the bladder and external urethral sphincter caused by damage or disease. Therapeutic management options fall into the categories of conservative, minimally invasive or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics to bladder tissue, numerous complications can ensue. Regenerative medicine uses combinations of cells and/or biomaterials to encourage regeneration of healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using the principles of regenerative medicine have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the US FDA, are ongoing in the USA in both children and adults to further evaluate the safety and efficacy of this technology for regenerating bladders. More studies are in progress and additional advances in this field can be anticipated.",
keywords = "Bladder replacement, Neurogenic bladder, Regenerative medicine, Stem cell, Tissue engineering",
author = "Roberto Soler and Claudius Fullhase and Anthony Atala",
year = "2009",
month = "3",
day = "1",
doi = "10.2217/14750708.6.2.177",
language = "English",
volume = "6",
pages = "177--184",
journal = "Therapy",
issn = "2044-9038",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Regenerative medicine strategies for treatment of neurogenic bladder

AU - Soler, Roberto

AU - Fullhase, Claudius

AU - Atala, Anthony

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Neurogenic bladder is a general term encompassing various neurologic dysfunctions in the bladder and external urethral sphincter caused by damage or disease. Therapeutic management options fall into the categories of conservative, minimally invasive or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics to bladder tissue, numerous complications can ensue. Regenerative medicine uses combinations of cells and/or biomaterials to encourage regeneration of healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using the principles of regenerative medicine have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the US FDA, are ongoing in the USA in both children and adults to further evaluate the safety and efficacy of this technology for regenerating bladders. More studies are in progress and additional advances in this field can be anticipated.

AB - Neurogenic bladder is a general term encompassing various neurologic dysfunctions in the bladder and external urethral sphincter caused by damage or disease. Therapeutic management options fall into the categories of conservative, minimally invasive or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics to bladder tissue, numerous complications can ensue. Regenerative medicine uses combinations of cells and/or biomaterials to encourage regeneration of healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using the principles of regenerative medicine have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the US FDA, are ongoing in the USA in both children and adults to further evaluate the safety and efficacy of this technology for regenerating bladders. More studies are in progress and additional advances in this field can be anticipated.

KW - Bladder replacement

KW - Neurogenic bladder

KW - Regenerative medicine

KW - Stem cell

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=69449097132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69449097132&partnerID=8YFLogxK

U2 - 10.2217/14750708.6.2.177

DO - 10.2217/14750708.6.2.177

M3 - Article

AN - SCOPUS:69449097132

VL - 6

SP - 177

EP - 184

JO - Therapy

JF - Therapy

SN - 2044-9038

IS - 2

ER -